Introduction
============

Toll-like receptor 4 (TLR4) is one of the principal receptors for bacterial endotoxin recognition and an important intracellular signal pathway of the innate immune response ([@b1]; [@b7]). Recently, there is evidence that endotoxin exposure during early life is protective against the development of atopy and asthma ([@b18]; [@b8]). *TLR4* is therefore reasonably suspected as a candidate gene for studying interaction between genetic variation and environmental factors for the development of atopic diseases.

Human *TLR4* gene is located at chromosome 9q32-33 and comprises three exons spanning about 10 kb (<http://www.ncbi.nlm.nih.gov>; AF177765). Twelve rare amino acid variants of *TLR4* were reported in 2001 ([@b17]). Raby and colleagues have identified an additional 29 polymorphisms of this gene ([@b13]). However, most association studies have concentrated on two positions: an A to G polymorphism at nucleotide 896 from the start codon of the human *TLR4* gene resulting in an aspartic acid to glycine substitution at position 299 of the amino acid sequence (Asp299Gly); and a C to T polymorphism at nucleotide position 1196 resulting in a threonine to isoleucine substitution at position 399 of the amino acid sequence (Thr399Ile). Many studies have reported an association between polymorphisms at *TLR4* Asp299Gly and Thr399Ile with clinical diseases ([@b9]; [@b10]; [@b19]; [@b21]). In 2000, Arbour and colleagues first reported that *TLR4* mutation were associated with endotoxin hyporesponsiveness in humans ([@b3]). Using an in vitro cultured cell approach, the same group reported that Asp299Gly mutation interrupted TLR4-mediated lipopolysaccaride (LPS) signaling ([@b16]). The study provides genetic evidence that human *TLR4* Asp299Gly mutation could be associated with differences in LPS responsiveness and, consequently, could alter the ability of the host to respond to environmental stimulus ([@b16]).

Recently, polymorphisms of *TLR4* were reported to be associated with the severity of atopy ([@b21]) and with a modified response to endotoxin in asthmatics ([@b19]). However, some studies were unable to confirm these two common polymorphisms on human *TLR4* gene or its associated atopy-related phenotypes ([@b13]; [@b11]). This study is therefore designed to screen the existence of these two common *TLR4* poly-morphisms (Asp299 Gly and Thr399Ile) and the association with atopy-related phenotypes in a Singaporean Chinese population.

Materials and methods
=====================

A total of 117 unrelated Singapore Chinese residents, aged from 9 to 72 years with a mean age of 31.7 ± 11.7 years, were investigated. Among them, atopy was evident in 66 subjects, and 51 were non-atopic. In atopic subjects, 61 experienced allergic rhinitis. Twenty-one patients had concomitant asthma and 17 of them were atopic. They were randomly called during a national rhinitis survey study to attend a rhinologic examination in the ENT outpatient clinic of the National University Hospital of Singapore. All subjects were carefully interviewed by an attending physician for their medical and family history, and a thorough inspection of the nose was performed. Peripheral blood samples were taken for allergy screening tests and for DNA extraction. All study subjects gave their informed consent prior to the study. This study was approved by the Institutional Review Board of the National University of Singapore and funded by the Academic Research Fund from the same university.

Diagnosis of atopy and its related diseases were made according to the following criteria ([@b4]):

1.  Atopy: a positive serum specific IgE (equal or more than 0.35 U/mL) to at least one of the inhalant allergens (house dust mites) tested.

2.  Rhinitis: the occurrence of two or more symptoms (nasal obstruction, rhinorrhea, sneezing, and itchy nose) on most days during the past year. If patients also had atopy, a diagnosis of allergic rhinitis was given.

3.  Asthma: a history of paroxysmal attacks of breathlessness commonly associated with a tightness of the chest and wheezing as previously confirmed by a physician.

Genomic DNA was extracted using a modified phenol-chloroform procedure. The polymorphism of *TLR4* was identified by sequence analysis in 117 subjects. PCR was carried out in a volume of 25 μL containing 30 ng genomic DNA, 10 × buffer, 0.2 mmol/L dNTPs, and 1 unit Taq polymerase (Qiagen, Hilden, Germany). The primers were: 5′-TCT AGA GGG CCT GTG CAA TT-3′ (forward) and 5′-TGA AAA CTC ACT CAT TTG TTT CAA-3′ (reverse) at a concentration of 0.4 μmol/L ([@b9]). PCR were optimized using denaturing for 2 min at 94 °C. The PCR cycle was set at 94 °C for 30 s, 54 °C for 30 s, and 72 °C for 40 s totally for 35 cycles, followed by 72 °C for 5 min. The sizes of the generated PCR products were 496 bp. Before sequencing, the PCR products were purified with QIAquick PCR purification kit (Qiagen, Hilden, Germany). Sequencing reactions were performed using the BIG Dye Terminator Cycle Sequencing Ready Reaction Kit (PE Applied Biosystems, Foster City, CA, USA). The sequenced products were purified by ethanol precipitation, following which the DNA pellet was dissolved in 4 μL of loading dye (Deionized formamide, PE Applied Biosystems, Foster City, CA, USA) and analyzed on an Applied Biosystems Genetic Analyser 3100 (PE Applied Biosystems, Foster City, CA, USA) in the Department of Pediatrics, National University of Singapore.

Results and discussion
======================

In all 117 subjects, we were unable to identify polymorphisms either at *TLR4* Asp299Gly or Thr399Ile. It appeared that the allele frequencies of mutation at these two positions are rare (lower than 1%) in the Singaporean Chinese population. This study indicated that all sequenced samples had Asp at amino acid 299 and Thr at amino acid 399 ([Figure 1](#fig1){ref-type="fig"}). In addition, we were unable to detect any polymorphism within the DNA fragments that were amplified and sequenced in this study.

![Sequence analysis of *TLR4* at amino acid position of 299 and 399. (a) AA homozygote at amino acid position 299; (b) CC homozygote at amino acid position 399. All sequences are 5′-3′.](tcrm0103-243-f1){#fig1}

Allele frequencies of *TLR4* Asp299Gly and Thr399Ile are found to be low in published studies. Asp299Gly is present at frequencies between 3.3% and 9.4%, while those of Thr399Ile are between 3.7% and 11% in several Caucasian studies ([Table 1](#tbl1){ref-type="table"}). A study performed in 32 asthmatic Japanese showed that Gly299 variant was undetectable in all patients ([@b11]). In another Japanese study, the Asp299Gly allele of the *TLR4* gene was undetectable in any of the specimens from 107 healthy volunteers and 168 patients with various diseases ([@b12]). From the available data, it seems that the polymorphisms of *TLR4* at amino acid position of 299 and 399 are rare in Asian population.

###### 

Summary of association studies regarding the polymorphisms at Asp299Gly and Thr399Ile

  Author(s)   Country/ethnic group           Nr of study subjects          Asp299Gly G allele frequency (%)   Thr399Ile T allele frequency (%)   Association with diseases   
  ----------- ------------------------------ ----------------------------- ---------------------------------- ---------------------------------- --------------------------- ----------------------------------------------------------------------
  [@b2]       US                             Patients: 77 Controls: 39     NA                                 NA                                 Yes                         Gram-negative infections
  [@b9]       France                         Patients: 91 Controls: 73     6--8                               6.6--11                            Yes                         Gram-negative septic shock
  [@b19]      Germany                        334                           8.3                                8.6                                Yes                         Modify endotoxin effects on asthma
  [@b10]      Australia                      118                           6.6--9.4                           6.6--9.4                           Yes                         Systemic inflammatory hyporesponsiveness 100% linkage disequilibrium
  [@b14]      Australia                      190                           6.05                               5.8                                Yes                         Multiple sclerosis
  [@b21]      US (Caucasians)                Family: 336                   5.9--8.1                           NA                                 Yes and No                  Atopy severity, but not asthma
  [@b13]      Canada (various populations)   90                            NA                                 NA                                 No                          Asthma or atopy-related phenotypes
  [@b11]      Japan                          32                            Not detected                       NA                                 No                          Asthma
  [@b5]       Germany                        Patients: 122 Control: 122    4.13.3                             4.53.7                             No                          Chronic periodontitis
  [@b17]      US (Caucasians)                348                           7                                  7                                  NA                          NA
  [@b12]      Japan                          Patients: 168 Controls: 107   Not detected                       NA                                 NA                          NA

**Abbreviations:** NA, not available.

Exposure to bacterial endotoxin has received considerable attention as a potential risk factor for the development of asthma and atopic diseases ([@b15]). As a receptor for LPS, *TLR4* is one of the most commonly investigated candidate genes for studying interaction between genetic variation and environmental factors for the development of atopic or atopy-related diseases. Although associations between polymorphisms of Asp299Gly and Thr399Ile at *TLR4* gene and atopic diseases have been reported by some studies, they may not be the key players in the development of atopic phenotypes. Otherwise, one could expect to confirm these polymorphisms in a different population since allergic disease is a common disease worldwide.

*TLR4* is a candidate gene for atopic diseases because of its important biologic characteristics. It is possible that polymorphisms at other positions of *TLR4* might play an important role in atopy-related phenotypes and that is in combination with the environmental exposure of bacterial endotoxin. Alternatively, it is also possible that genetic susceptibility to asthma and atopic-related phenotypes might be different in various populations. This notion was supported by the recent genome-wide studies for identifying the asthma susceptibility loci in ethnically diverse populations ([@b20]; [@b6]). In view of the conflicting evidence, future studies are needed to identify the key genes for atopic phenotypes and to investigate the interactions between genetic and environmental factors influencing the complex trait of allergic diseases.

In summary, we were unable to detect the polymorphisms at Asp299Gly or Thr399Ile of *TLR4* in Singaporean Chinese. Our results suggest that these two polymorphisms in *TLR4* could not be the key player in Singaporean Chinese with atopy or atopic-related phenotypes.
